SCHEMBL25042402

SCHEMBL25042402

FC(F)(F)C1CCN(c2ccc(Br)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
CYP3A4 P08684 2/20 0.39
AKR1C3 P42330 1/20 0.39
MGLL Q99685 1/20 0.37
MAPT P10636 2/20 0.37
IGF1R P08069 1/20 0.37
USP2 O75604 2/20 0.36
KMT2A Q03164 1/20 0.36
NOTUM Q6P988 1/20 0.36
NPY5R Q15761 1/20 0.35
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HRH3 Q9Y5N1 2/20 0.35
HRH4 Q9H3N8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10035931 0.81 MAPT (0.53) L3MBTL3L3MBTL1CYP3A4MGLLMAPT
SCHEMBL15189523 0.81 ADRB1 (0.48) L3MBTL3L3MBTL1CYP3A4AKR1C3MGLL
SCHEMBL30885146 0.81 L3MBTL3 (0.40) L3MBTL3L3MBTL1CYP3A4MGLLMAPT
SCHEMBL7755392 0.81 MBTD1 (0.52) L3MBTL3L3MBTL1CYP3A4MGLLNOTUM
SCHEMBL31053609 0.81 MAPT (0.40) L3MBTL3L3MBTL1CYP3A4MGLLMAPT
SCHEMBL20005149 0.80 AKR1C3 (0.47) L3MBTL3L3MBTL1SLC6A2SLC6A4AKR1C3
SCHEMBL31053587 0.80 CYP3A4 (0.44) L3MBTL3L3MBTL1CYP3A4MGLLMAPT
SCHEMBL14167573 0.79 RORC (0.43) L3MBTL3L3MBTL1SLC6A2SLC6A4AKR1C3
SCHEMBL31053578 0.79 HRH3 (0.47) L3MBTL3L3MBTL1CYP3A4MGLLMAPT
SCHEMBL25042072 0.79 HRH3 (0.47) L3MBTL3L3MBTL1CYP3A4MGLLMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 US disclosed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 EP disclosed
CN-118076581-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-24 CN disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 L3MBTL3 2279/4885L3MBTL1 1984/4885SLC6A2 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.